About: High-dose imatinib in newly diagnosed chronic-phase chronic myeloid leukemia: high rates of rapid cytogenetic and molecular responses     Goto   Sponge   NotDistinct   Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 31 August 2009

AttributesValues
rdf:type
description
  • videnskabelig artikel (da)
  • article científic (ca)
  • articolo scientifico (it)
  • artigo científico (pt)
  • bilimsel makale (tr)
  • vedecký článok (sk)
  • vetenskaplig artikel (sv)
  • vědecký článek (cs)
  • wetenschappelijk artikel (nl)
  • wissenschaftlicher Artikel (de)
  • научни чланак (sr)
  • article scientifique (fr)
  • artículu científicu espublizáu en 2009 (ast)
  • наукова стаття, опублікована в серпні 2009 (uk)
  • scientific article published on 31 August 2009 (en)
  • مقالة علمية نشرت في 31 أغسطس 2009 (ar)
publication date
publication date
language of work or name
language of work or name
cites work
cites work
author name string
author name string
  • Bayard L Powell
  • John M Burke
  • Mansoor Saleh
  • Stuart L Goldberg
  • Robert Kerr
  • Karen McDougall
  • Rationale and Insight for Gleevec High-Dose Therapy (RIGHT) Trial Study Group
rdfs:label
  • High-dose imatinib in newly diagnosed chronic-phase chronic myeloid leukemia: high rates of rapid cytogenetic and molecular responses (en)
  • High-dose imatinib in newly diagnosed chronic-phase chronic myeloid leukemia: high rates of rapid cytogenetic and molecular responses (nl)
  • High-dose imatinib in newly diagnosed chronic-phase chronic myeloid leukemia: high rates of rapid cytogenetic and molecular responses (ast)
skos:prefLabel
  • High-dose imatinib in newly diagnosed chronic-phase chronic myeloid leukemia: high rates of rapid cytogenetic and molecular responses (en)
  • High-dose imatinib in newly diagnosed chronic-phase chronic myeloid leukemia: high rates of rapid cytogenetic and molecular responses (nl)
  • High-dose imatinib in newly diagnosed chronic-phase chronic myeloid leukemia: high rates of rapid cytogenetic and molecular responses (ast)
name
  • High-dose imatinib in newly diagnosed chronic-phase chronic myeloid leukemia: high rates of rapid cytogenetic and molecular responses (en)
  • High-dose imatinib in newly diagnosed chronic-phase chronic myeloid leukemia: high rates of rapid cytogenetic and molecular responses (nl)
  • High-dose imatinib in newly diagnosed chronic-phase chronic myeloid leukemia: high rates of rapid cytogenetic and molecular responses (ast)
author
author
title
title
  • High-dose imatinib in newly diagnosed chronic-phase chronic myeloid leukemia: high rates of rapid cytogenetic and molecular responses (en)
page(s)
page(s)
  • 4754-4759
instance of
instance of
main subject
main subject
PubMed ID
PubMed ID
PubMed ID
  • 19720924
published in
published in
issue
Faceted Search & Find service v1.16.117 as of May 05 2024


Alternative Linked Data Documents: ODE     Content Formats:   [cxml] [csv]     RDF   [text] [turtle] [ld+json] [rdf+json] [rdf+xml]     ODATA   [atom+xml] [odata+json]     Microdata   [microdata+json] [html]    About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data] Valid XHTML + RDFa
OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 180 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software